Glaxo trade secret claim in Zantac case rejected by Judge Boyle.
This article was originally published in The Tan Sheet
Executive Summary
GLAXO TRADE SECRET CLAIMS REJECTED IN ZANTAC CASE AGAINST NOVOPHARM by Raleigh, N.C. federal court Judge Terrence Boyle in his July 5 ruling in the ranitidine patent case. Glaxo Wellcome's trade secret misappropriation claims against Novopharm "do not withstand even cursory examination under law," Boyle stated.